2026-08-31-2_articles_updated

您好 Zhilong，大模型今日为您筛选出 2 篇高度相关论文：

期刊: Nature Communications

标题: 激素受体阳性、HER2低表达乳腺癌术前抗HER2抗体偶联药物SHR-A1811治疗：一项II期临床试验 (HELEN-015)

英文标题: Neoadjuvant anti-HER2 antibody-drug conjugate SHR-A1811 in Hormone Receptor-positive, HER2-low Breast Cancer: A Phase 2 Clinical Trial (HELEN-015)

链接: https://www.nature.com/articles/s41467-026-77041-x

期刊: Digital Health

标题:

英文标题: [Articles] Artificial intelligence-based tumour infiltrating lymphocyte quantification in patients with triple-negative breast cancer: an independent validation study

链接: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(26)00339-6/fulltext?rss=yes